|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/01 | |
| A61K 38/03 | |||
| A61K 38/04 | |||
| A61P 29/00 | |||
| A61P 1/04 |
| (11) | Patento numeris | 2224941 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09753693.2 |
| Europos patento paraiškos padavimo data | 2009-06-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-02-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2009/003936 |
| Data | 2009-06-02 |
| (87) | Numeris | WO 2009/144038 |
| Data | 2009-12-03 |
| (30) | Numeris | Data | Šalis |
| PCT/EP2008/0043 | 2008-05-30 | WO |
| (72) |
BONNY, Christophe, CH
|
| (73) |
Xigen S.A.,
Route de la Corniche 4, 1066 Epalinges,
CH
|
| (54) | USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES |
| USE OF CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON-CHRONIC INFLAMMATORY DIGESTIVE DISEASES |